Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702
- Citation:
- J Clin Oncol vol 41 (5) 1079-91
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 12
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA233163, UG1CA189858, UG1CA233180, UG1CA233290, UG1CA233320, UG1CA233337, UG1CA233339, UG1CA189954, U10CA180863 to the Canadian Cancer Trials Group; UG1CA233234 ECOG–ACRIN ; U10CA180868 NRG Oncology; U10CA180888 SWOG
- Corr. Author:
- Authors:
- Seohyuk Lee Chao Ma Qian Shi Pankaj Kumar Felix Couture Philip Kuebler Smitha Krishnamurthi DeQuincy Lewis Benjamin Tan Richard M. Goldberg Alan Venook Charles Blanke Eileen M. O'Reilly Anthony F. Shields Jeffrey A. Meyerhardt
- Networks:
- CA136, HEARTLAND, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-OH007, OH027, OR013, SCOR
- Study
- Alliance-A151939
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- N/A, 3
- Keywords: